EXAI
Price
$4.78
Change
-$0.53 (-9.98%)
Updated
Nov 15, 03:17 PM (EDT)
125 days until earnings call
GHRS
Price
$8.88
Change
-$0.09 (-1.00%)
Updated
Nov 15, 03:02 PM (EDT)
104 days until earnings call
Ad is loading...

EXAI vs GHRS

Header iconEXAI vs GHRS Comparison
Open Charts EXAI vs GHRSBanner chart's image
Exscientia
Price$4.78
Change-$0.53 (-9.98%)
Volume$1.5K
CapitalizationN/A
GH Research
Price$8.88
Change-$0.09 (-1.00%)
Volume$100
CapitalizationN/A
EXAI vs GHRS Comparison Chart
Loading...
EXAI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GHRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
EXAI vs. GHRS commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXAI is a StrongSell and GHRS is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (EXAI: $5.31 vs. GHRS: $8.97)
Brand notoriety: EXAI and GHRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EXAI: 110% vs. GHRS: 126%
Market capitalization -- EXAI: $694.66M vs. GHRS: $466.69M
EXAI [@Biotechnology] is valued at $694.66M. GHRS’s [@Biotechnology] market capitalization is $466.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXAI’s FA Score shows that 0 FA rating(s) are green whileGHRS’s FA Score has 1 green FA rating(s).

  • EXAI’s FA Score: 0 green, 5 red.
  • GHRS’s FA Score: 1 green, 4 red.
According to our system of comparison, both EXAI and GHRS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXAI’s TA Score shows that 6 TA indicator(s) are bullish while GHRS’s TA Score has 5 bullish TA indicator(s).

  • EXAI’s TA Score: 6 bullish, 4 bearish.
  • GHRS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, EXAI is a better buy in the short-term than GHRS.

Price Growth

EXAI (@Biotechnology) experienced а +0.57% price change this week, while GHRS (@Biotechnology) price change was +4.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.93%. For the same industry, the average monthly price growth was -3.18%, and the average quarterly price growth was +1.55%.

Reported Earning Dates

EXAI is expected to report earnings on Mar 20, 2025.

GHRS is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-5.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXAI($695M) has a higher market cap than GHRS($467M). GHRS YTD gains are higher at: 54.655 vs. EXAI (-17.161).
EXAIGHRSEXAI / GHRS
Capitalization695M467M149%
EBITDAN/AN/A-
Gain YTD-17.16154.655-31%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
EXAIGHRS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 3 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
0%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
EXAI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
GHRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

EXAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXAI has been loosely correlated with RXRX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXAI
1D Price
Change %
EXAI100%
-5.35%
RXRX - EXAI
54%
Loosely correlated
-5.60%
BEAM - EXAI
47%
Loosely correlated
-4.33%
CRSP - EXAI
43%
Loosely correlated
-5.90%
ABCL - EXAI
42%
Loosely correlated
-5.48%
XERS - EXAI
41%
Loosely correlated
-3.17%
More

GHRS and

Correlation & Price change

A.I.dvisor tells us that GHRS and EXAI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GHRS and EXAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
-2.92%
EXAI - GHRS
24%
Poorly correlated
-5.35%
VERV - GHRS
24%
Poorly correlated
-7.08%
WVE - GHRS
23%
Poorly correlated
-4.40%
XNCR - GHRS
23%
Poorly correlated
-0.47%
SILO - GHRS
23%
Poorly correlated
+4.55%
More